Derived from Latin, the notion “in vitro diagnostics” refers to tests such as blood, tissues, or urine tests that are carried out in controlled environment outside a living organism. In vitro diagnostics tests are usually held in a laboratory, while sometimes they are carried out at home. In vitro diagnostics is used in hematology, clinical chemistry, molecular diagnostics, immunology, etc.
Development of technologies, the growing incidence of respiratory, sexually transmitted diseases are among the top factors contributing to the market growth. In vitro diagnostics gains popularity worldwide and the market grows swiftly, especially in developing countries such as India and China. Alere Inc, Beckman Coulter Inc and Diasorin Diagnostic S.P.A. are amidst majors are active in the in vitro diagnostics market.
The Catalogue includes research reports offering cutting-edge data on the market for in vitro diagnostics. The reports provide analyses market’s drivers and restraints. The research studies contain profiles of leading market participants. Overviews of the competitive landscape and technologies are available in the reports too.
Publications found:
36,825
Sort by:
2017-2021 France Hospital Clinical Chemistry and Immunodiagnostics Market Forecasts: Reagent and Instrument Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
US$ 3,465.00
... a comprehensive analysis of the French hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the French clinical chemistry and immunodiagnostic hospital laboratory practice, as well ... forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in French hospitals, including controls, calibrators and ...
January 2017
508 pages
2017-2021 Germany Hospital Clinical Chemistry and Immunodiagnostics Market Forecasts: Reagent and Instrument Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
US$ 3,465.00
... a comprehensive analysis of the German hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the German clinical chemistry and immunodiagnostic hospital laboratory practice, as well ... forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in German hospitals, including controls, calibrators and ...
January 2017
523 pages
2017-2021 Italy Hospital Clinical Chemistry and Immunodiagnostics Market Forecasts: Reagent and Instrument Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
US$ 3,465.00
... a comprehensive analysis of the Italian hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Italian clinical chemistry and immunodiagnostic hospital laboratory practice, as well ... forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in Italian hospitals, including controls, calibrators and ...
January 2017
521 pages
2017-2021 Japan Hospital Clinical Chemistry and Immunodiagnostics Market Forecasts: Reagent and Instrument Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
US$ 4,365.00
... a comprehensive analysis of the Japanese hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Japanese clinical chemistry and immunodiagnostic hospital laboratory practice, as well ... forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in Japanese hospitals, including controls, calibrators and ...
January 2017
520 pages
2017-2021 Spain Hospital Clinical Chemistry and Immunodiagnostics Market Forecasts: Reagent and Instrument Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
US$ 3,465.00
... a comprehensive analysis of the Spanish hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Spanish clinical chemistry and immunodiagnostic hospital laboratory practice, as well ... forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in Spanish hospitals, including controls, calibrators and ...
January 2017
514 pages
2017-2021 UK Hospital Clinical Chemistry and Immunodiagnostics Market Forecasts: Reagent and Instrument Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
US$ 3,465.00
... presents a comprehensive analysis of the UK hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the UK clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key ... sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in UK hospitals, including controls, calibrators and ...
January 2017
523 pages
2017-2021 US Hospital Clinical Chemistry and Immunodiagnostics Market Forecasts: Reagent and Instrument Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
US$ 7,020.00
... presents a comprehensive analysis of the US hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the US clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key ... sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in US hospitals, including controls, calibrators and ...
January 2017
543 pages
2017-2021 US Hospital Coagulation Market Forecasts: Reagent and Instrument Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
US$ 5,670.00
... , 28 tables, and presents a comprehensive analysis of the US hospital coagulation testing market, including: Major issues pertaining to the US hospital coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market ...
January 2017
411 pages
2017 Emerging Coagulation Technologies and Strategic Profiles of Leading Suppliers
US$ 3,465.00
... assessments of such technologies as chromogenic substrates, monoclonal and polyclonal antibodies, immunoassays, IT, molecular diagnostics, and their potential applications for coagulation testing. The report also includes strategic assessments of current and emerging suppliers of coagulation instruments and reagents, products, including marketing tactics, technological ...
January 2017
124 pages
2017 Emerging Cancer Diagnostic Tests, and Strategic Profiles of Leading Reagent and Instrument Suppliers
US$ 3,465.00
... clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing ... applications. The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics ...
January 2017
286 pages
2017-2021 Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities
US$ 4,815.00
... technologies. During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the ... report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, Europe (France, Germany, Italy, Spain, UK) and Japan ...
January 2017
120 pages
2017 Emerging Clinical Chemistry and Immunodiagnostic Tests, and Strategic Profiles of Leading Reagent and Instrument Suppliers
US$ 3,465.00
... 320-page report presents an overview of the clinical significance and market needs for major Chemistry, TDM, Endocrine, Cancer, Immunoprotein, and Abused ... . The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product ...
January 2017
320 pages
2017 Emerging Transfusion Diagnostic Typing, Grouping and NAT Screening Tests, and Strategic Profiles and Leading Reagent and Instrument Suppliers
US$ 3,465.00
... analysis of the clinical significance and market needs for major transfusion diagnostic typing, grouping, and infectious disease screening assays, including NAT ... . The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, ...
January 2017
225 pages
2017 Emerging Tumor Markers, and Strategic Profiles of Leading Reagent and Instrument Suppliers
US$ 3,465.00
... major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical ... clinical significance and market needs for both current and emerging tumor markers, as well as extensive listings of companies, universities and research centers developing ...
January 2017
286 pages
2017-2021 France Enteric Disease Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technologies
US$ 1,980.00
... report from VPGMarketResearch.com presents detailed analysis of the French Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium ... technologies and products; and- Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
322 pages
2017-2021 Germany Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 1,755.00
... report from VPGMarketResearch.com presents detailed analysis of the German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
283 pages